Career history of F. Andrew Dorr
Former positions of F. Andrew Dorr
| Companies | Position | Start | End |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | 2017-04-20 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Chief Operating Officer | 2004-07-31 | 2004-07-31 |
| IONIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 1995-12-31 | 2002-12-31 |
Training of F. Andrew Dorr
| Davidson College | Undergraduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- F. Andrew Dorr
- Experience
